Comera Life Sciences Holdings, Inc. (CMRA)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Feb 18, 2026
-50.00%
Market Cap 3.07K
Revenue (ttm) 1.00M
Net Income (ttm) -9.35M
Shares Out 30.74M
EPS (ttm) -0.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,875
Average Volume 5,637
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0002
Beta -81.03
RSI 35.25
Earnings Date n/a

About CMRA

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 13
Stock Exchange OTCMKTS
Ticker Symbol CMRA
Full Company Profile

Financial Performance

In 2022, CMRA's revenue was $633,102, an increase of 97.95% compared to the previous year's $319,832. Losses were -$18.38 million, 237.1% more than in 2021.

Financial Statements

News

There is no news available yet.